243 related articles for article (PubMed ID: 11138408)
21. Antigen recognition in the islets changes with progression of autoimmune islet infiltration.
Lindsay RS; Corbin K; Mahne A; Levitt BE; Gebert MJ; Wigton EJ; Bradley BJ; Haskins K; Jacobelli J; Tang Q; Krummel MF; Friedman RS
J Immunol; 2015 Jan; 194(2):522-30. PubMed ID: 25505281
[TBL] [Abstract][Full Text] [Related]
22. Molecular targeting of islet autoantigens.
Stadinski B; Kappler J; Eisenbarth GS
Immunity; 2010 Apr; 32(4):446-56. PubMed ID: 20412755
[TBL] [Abstract][Full Text] [Related]
23. Molecular analysis of the pathogenesis of beta-cell destruction in insulin-dependent diabetes mellitus.
Lernmark A; Bärmeier H; Dube S; Hagopian W; Karlsen AE; Markholst H; Wilson C; Wassmuth R
West J Med; 1990 Nov; 153(5):499-502. PubMed ID: 1979704
[No Abstract] [Full Text] [Related]
24. The role of interleukin-1 in the pathogenesis of insulin-dependent diabetes mellitus.
Diabetologia; 1994 Oct; 37(10):42-3. PubMed ID: 7851688
[No Abstract] [Full Text] [Related]
25. CD95 mediated T cell apoptosis and its relevance to immune deviation.
Varadhachary AS; Salgame P
Oncogene; 1998 Dec; 17(25):3271-6. PubMed ID: 9916989
[TBL] [Abstract][Full Text] [Related]
26. Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans.
Wang H; Li Y; Sun Q; Yang G
Chin Med J (Engl); 2000 May; 113(5):433-6. PubMed ID: 11776099
[TBL] [Abstract][Full Text] [Related]
27. [Type 1 diabetes mellitus and immunopathology].
Koike T
Nihon Rinsho; 2002 Jul; 60 Suppl 7():399-406. PubMed ID: 12238080
[No Abstract] [Full Text] [Related]
28. New concepts of the etiopathogenesis and treatment of insulin-dependent diabetes mellitus.
Bach JF
Clin Rev Allergy Immunol; 2000 Dec; 19(3):217-25. PubMed ID: 11138406
[No Abstract] [Full Text] [Related]
29. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
Yang Y; Santamaria P
J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
[No Abstract] [Full Text] [Related]
30. [Immunogenetic mechanisms in the pathogenesis of type 1 diabetes mellitus].
Tatoń J; Czech A; Podgórski G
Pol Tyg Lek; 1984 Aug; 39(34):1141-6. PubMed ID: 6390380
[No Abstract] [Full Text] [Related]
31. Simultaneous stimulation of Fas-mediated apoptosis and blockade of costimulation prevent autoimmune diabetes in mice induced by multiple low-dose streptozotocin.
Jin Y; Qu A; Wang GM; Hao J; Gao X; Xie S
Gene Ther; 2004 Jun; 11(12):982-91. PubMed ID: 15042121
[TBL] [Abstract][Full Text] [Related]
32. The role of Fas/FasL interactions in the regulation of B cell function.
Jacobson BA; Rothstein TL; Marshak-Rothstein A
Behring Inst Mitt; 1996 Oct; (97):185-99. PubMed ID: 8950476
[TBL] [Abstract][Full Text] [Related]
33. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
Tisch R; Yang XD; Singer SM; Liblau RS; Fugger L; McDevitt HO
Nature; 1993 Nov; 366(6450):72-5. PubMed ID: 8232539
[TBL] [Abstract][Full Text] [Related]
34. CD95 ligand in graft rejection.
Yagita H; Seino K; Kayagaki N; Okumura K
Nature; 1996 Feb; 379(6567):682. PubMed ID: 8602212
[No Abstract] [Full Text] [Related]
35. CD95/CD95 ligand-mediated counterattack does not block T cell cytotoxicity.
Jekle A; Obst R; Lang F; Rammensee HG; Gulbins E
Biochem Biophys Res Commun; 2000 Jun; 272(2):395-9. PubMed ID: 10833425
[TBL] [Abstract][Full Text] [Related]
36. The pro-apoptotic BH3-only protein Bid is dispensable for development of insulitis and diabetes in the non-obese diabetic mouse.
Mollah ZU; Wali J; McKenzie MD; Krishnamurthy B; Graham KL; Fynch S; Szanyi J; Santamaria P; Brodnicki T; Allison J; Strasser A; Kay TW; Thomas HE
Apoptosis; 2011 Aug; 16(8):822-30. PubMed ID: 21644000
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment.
Sayama K; Imagawa A; Okita K; Uno S; Moriwaki M; Kozawa J; Iwahashi H; Yamagata K; Tamura S; Matsuzawa Y; Hanafusa T; Miyagawa J; Shimomura I
Diabetologia; 2005 Aug; 48(8):1560-4. PubMed ID: 15991022
[TBL] [Abstract][Full Text] [Related]
38. Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet beta cells in non-obese diabetic mice.
Suarez-Pinzon WL; Power RF; Rabinovitch A
Diabetologia; 2000 Sep; 43(9):1149-56. PubMed ID: 11043861
[TBL] [Abstract][Full Text] [Related]
39. Autoimmune endocrine diseases.
De Baets MH
Year Immunol; 1989; 4():264-75. PubMed ID: 2564710
[No Abstract] [Full Text] [Related]
40. Immune cells, pancreas development, regeneration and type 1 diabetes.
Homo-Delarche F; Drexhage HA
Trends Immunol; 2004 May; 25(5):222-9. PubMed ID: 15099561
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
